Medtech Manufacturing for Innovators & Start Ups: What You Most Need to Know

Insights from a deep dive into medical device innovation and production with GCMI’s Saylan Lukas and GaMEP’s Dean Hettenbach

Given the patient safety requirements codified in the United States Code of Federal Regulations overseen and enforced by the Food and Drug Administration, medical device innovation is a challenging enterprise to say the least.

 

It is also a landscape filled with pitfalls that need a holistic, long range view to avoid them. Considering what manufacturing at scale means for a new device or technology is one such pitfall that needs consideration earlier in the design and development process than one might know or believe.

 

Design decisions with manufacturing at the right scale need to be made upfront, even if large-scale production seems far off. A device might serve its purpose perfectly as a 3D printed prototype, but producing it at scale for clinical use based on designs only appropriate for small batch production can become an expensive nightmare.

 

Last month, GCMI Interim Executive Director Saylan Luke and Georgia Manufacturing Extension Partnership’s Dean Hettenbauch unpacked the common challenges that many face when entering the medical device space and the steps to take to avoid common pitfalls [particularly as it relates to manufacturing].

 

While we invite you to check out the hour long recording full of high value information and insights, but as long as you’re here, check out some of the top takeaways.

 

Engage regulators early, but be well prepared.

Start the process of engaging the FDA (assuming you intend to market your device in the United States) as soon as possible. They are there to help and more well equipped and committed than ever to do so. BUT, put in the time prior to any engagement with regulators to be as well informed as possible. Know that they don’t answer vague questions. Seriously consider, vet and engage a regulatory consultant with experience specific to your technology and its prospective pathway or pathways.



CLICK HERE TO KEEP READING
August 17, 2026
Biotechnology Innovation Organization (BIO) Senior Vice President of Science & Regulatory Affairs Annetta Beauregard issued the following statement on the release of the Prescription Drug User Fee Act (PDUFA) VIII commitment letter: “For more than 30 years, PDUFA has helped deliver hundreds of new medicines to American patients. As a lead industry negotiator for the PDUFA VIII agreement, BIO supports the PDUFA VIII commitment letter and its strengthening of regulatory review, advancing innovation, and helping deliver safe and effective treatments to patients. “Specifically, the PDUFA VIII agreement includes important commitments that bolster the FDA’s core review activities, ensure accountability for predictable performance, improve financial sustainability and improve communication, transparency and efficiency. “Timely, bipartisan reauthorization of PDUFA is vital for protecting the health of Americans, strengthening U.S. competitiveness, and maintaining America’s global leadership in medical innovation. BIO is committed to working with Congress to ensure reauthorization by September 30, 2027.” The FDA has announced plans to hold a hybrid public meeting at 9am on 9/16 to discuss the proposed enhancements for the reauthorization of PDUFA for fiscal years (FYs) 2028 through 2033. Learn More about PDUFA and the PDUFA VIII commitment letter HERE .
August 10, 2026
Award recipients will be recognized at the Golden Helix Awards Ceremony on August 25 ATLANTA, Ga. – Georgia Life Sciences today announced the recipients of the 2026 Golden Helix Awards, recognizing the individuals, organizations, partnerships, and investments that are advancing innovation, improving patient care, strengthening Georgia's economy, and shaping the future of the state's life sciences ecosystem. The honorees will be celebrated during the Georgia Life Sciences Summit Welcome Reception and Golden Helix Awards Ceremony on Tuesday, August 25, at the Sandy Springs Performing Arts Center, kicking off Georgia's premier gathering of life sciences leaders ahead of the Summit on Wednesday, August 26. "For nearly two decades, the Golden Helix Awards have celebrated the people and organizations whose vision, collaboration, and commitment continue to elevate Georgia as a global leader in life sciences," said Maria Thacker Goethe, President & CEO of Georgia Life Sciences. "This year's recipients represent the extraordinary innovation taking place across our state—from groundbreaking research and transformative investments to workforce development and community impact. We are proud to recognize their achievements and the lasting difference they are making for patients, our economy, and the future of healthcare." 2026 Golden Helix Award Honorees Phoenix Award · Micron Biomedical, Emory University, and CDC – Industry-Academic Partnership Innovation Awards · Dr. Kyle Johnsen, University of Georgia · Focused Cryo Community Awards · Angela Gill Nelms, Biolocity · Frugal Science Academy · Jessica King Holden, Gwinnett Regional Science, Engineering + Innovation Fair · Dr. Marlo Vernon, Augusta University Deal of the Year Awards Economic Development · UCB · Shriners Children's Research Institute and Georgia Tech Acquisition · LymphaTech & Tactile Medical · Avanos Medical Financing · Altesa BioSciences Federal Grant · HEAL: Healthy Ameliorated Lymphatics, Georgia Institute of Technology · Manus & U.S. Department of Health and Human Services Administration for Strategic Preparedness and Response (HHS/ASPR) Emerging Leader of the Year · Dr. Ryan Devine, Medical Innovation Hub, Georgia Tech Legislator of the Year · Rep. Matt Dubnik (R-29) Teacher of the Year · Ana White, DeKalb High School of Technology North at Cross Keys The Golden Helix Awards recognize excellence across Georgia's life sciences ecosystem, honoring breakthrough scientific discoveries, strategic partnerships, commercial achievements, community leadership, and investments that strengthen the state's position as a national leader in biotechnology, medical technology, pharmaceuticals, research, and advanced manufacturing. The awards ceremony serves as the opening event of the 2026 Georgia Life Sciences Summit, bringing together executives, researchers, entrepreneurs, investors, and healthcare leaders, and academic institutions from across the state to celebrate innovation and explore opportunities shaping the future of Georgia's life sciences industry. The Georgia Life Sciences Summit will take place on Wednesday, August 26, at the Sandy Springs Performing Arts Center, featuring nationally recognized speakers, executive panels, CEO spotlights, networking opportunities, and the Solutions Corridor showcasing organizations driving the industry's continued growth. To learn more about the Georgia Life Sciences Summit or to register, visit https://www.galifesciences.org/summit.
August 7, 2026
One of the biggest benefits of becoming a Georgia Life Sciences Student Member is access to discounted registration for Georgia's premier life sciences conference—bringing together CEOs, researchers, entrepreneurs, investors, and innovators from across the state. Better yet, Student Membership is only $25 per year , making it one of the best investments you can make in your future. The Georgia Life Sciences Emerging Leaders Network (ELN) is the official student membership community of Georgia Life Sciences, created to connect students, postdoctoral researchers, and early-career professionals with Georgia's thriving life sciences ecosystem. As an ELN member, you'll build meaningful peer-to-peer relationships, engage with industry leaders, explore career opportunities, and gain access to professional development programs designed to help you launch a successful career in the life sciences. As a member, you'll have opportunities to: Connect with fellow students, postdocs, and emerging professionals from across Georgia. Expand your network through peer-to-peer engagement and professional networking events. Learn from industry leaders and gain exposure to Georgia's life sciences ecosystem. Participate in workforce and career development programming. Access Career Connections Student members also receive exclusive access to the Georgia Life Sciences Career Connections LinkedIn Group , where you can: Discover internships and job opportunities. Connect with employers, recruiters, and industry professionals. Stay informed about career fairs, networking events, and workforce initiatives. Engage with a growing community of future life sciences leaders. Student Member Benefits Georgia Life Sciences Student Membership: $25/year Georgia Life Sciences Summit Registration: $150 Access to the Emerging Leaders Network Career Connections LinkedIn Group Networking events and professional development opportunities Industry news, workforce resources, and member communications Whether you're exploring careers in biotechnology, medical devices, pharmaceuticals, diagnostics, digital health, or research, Georgia Life Sciences connects you to the people and opportunities that can help shape your future. Join today . Build your network. Advance your career.
MORE POSTS